Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

2.62
Delayed Data
As of Feb 12
 +0.07 / +2.75%
Today’s Change
2.38
Today|||52-Week Range
8.59
-37.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues6.6M12.3M16.2M35.4M
 
 
 
 
 
Cost of Goods Sold11.2M6.1M5.7M5.3M
 
 
 
 
 
Depreciation And Amortization971.0K926.0K473.0K386.0K
 
 
 
 
 
 
Operating ExpensesGross Income-5.5M5.3M10.0M29.8M
 
 
 
 
 
General Expenses20.0M27.0M28.4M51.3M
 
 
 
 
 
Research And Development11.8M18.6M21.0M41.4M
 
 
 
 
 
Total Operating Expenses32.1M34.0M34.6M57.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.5M-21.6M-18.4M-21.5M
 
 
 
 
 
Interest Expense On Debt2.6M2.6M2.7M2.7M
 
 
 
 
 
Other Expenses86.4M11.5M0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income58.3M-12.7M-21.0M-24.2M
 
 
 
 
 
Net Income58.3M-12.7M-21.0M-24.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.8M141.4M142.2M142.8M
 
 
 
 
 
Shares To Calculate EPS Diluted166.3M141.4M142.2M142.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.37-$0.09-$0.15-$0.17
 
 
 
 
 
EPS Diluted$0.37-$0.09-$0.15-$0.17